Friday, September 16, 2011 4:42:40 PM
Marc told me earlier this week that it takes a prescription in Europe just to buy Vitamin C!!
OUCH!
And I thought we had issues with the US FDA!
I got to thinking after Gold's recent bearish comments on IFUS about some good comparisons. I may work on a post for that this weekend. The theme being, to compare say CYTR to IFUS.
CYTR has no sales, a huge known cost going forward with its new drug trials, yet the market cap has been in the $100 million dollar area for years, as they burn through 5 to 20 million dollars or more per year,
and yet at today's price IFUS is sporting a tiny market cap of only about $350,000, for a company with a product that works, and that has real revenue, and product sales, that are climbing.
There are many good CYTR comparisons. Point being that I see IFUS as undervalued!
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM